Cargando…
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
Although high-dose methotrexate (HD-MTX) is the most effective drug against primary CNS lymphomas (PCNSL), outcome-determining variables related to its administration schedule have not been defined. The impact on toxicity and outcome of the area under the curve (AUC(MTX)), dose intensity (DI(MTX)) a...
Autores principales: | Ferreri, A J M, Guerra, E, Regazzi, M, Pasini, F, Ambrosetti, A, Pivnik, A, Gubkin, A, Calderoni, A, Spina, M, Brandes, A, Ferrarese, F, Rognone, A, Govi, S, Dell'Oro, S, Locatelli, M, Villa, E, Reni, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409565/ https://www.ncbi.nlm.nih.gov/pubmed/14735176 http://dx.doi.org/10.1038/sj.bjc.6601472 |
Ejemplares similares
-
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial
por: Joerger, M, et al.
Publicado: (2010) -
Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
por: Reni, M, et al.
Publicado: (2006) -
Second-line treatment for primary central nervous system lymphoma
por: Reni, M, et al.
Publicado: (1999) -
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
por: Fritsch, K, et al.
Publicado: (2017) -
Validation of the Cockroft-Gault formula for estimation of creatinine clearance in the critically ill population
por: Kharbanda, M, et al.
Publicado: (2006)